Open Accessibility Menu

Coronavirus (COVID-19) Update - We are open with your safety in mind. Click here to learn more.

For information about COVID-19, the vaccine, or to view additional resources, please click here.

Neurology

About Us

We are now offering online virtual health visits. Please contact us at (202) 741-2700 to request an appointment.

The Department of Neurology at The George Washington University Medical Faculty Associates is a premier program that offers patients high quality, compassionate healthcare for conditions ranging from back pain and sleep disturbances to stroke and the most complex neuromuscular disorders.

Our medical team consists of board-certified neurologists, nurses, EEG technicians, EMG technologists and clinical researchers. Our neurologists are on the forefront of advances in their fields with continuing education and by teaching at The George Washington University School of Medicine & Health Sciences. We offer fellowships in neurophysiology and sleep disorders.

To diagnose neuromuscular disorders we have invested in an advanced electrodiagnostic laboratory that has achieved the highest possible accreditation with exemplary status from the American Association of Neuromuscular & electrodiagnostic Medicine. Ours is the only lab in metropolitan Washington with this designation. It is proof of our commitment to clinical excellence and to providing the highest quality patient care.

We accept most insurance plans and our knowledgeable administrative staff is happy to assist with the approval process and pre-certifications.

Read the latest issue of Neurotransmitter: A magazine of the GW Institute for Neuroscience and the GW Hospital's Neurological Institute here.


Online Forms:

How to Manage Back Pain During COVID-19

Dr. Akshay Garg and Dr. Geet Paul, Physical Medicine & Rehabilitation specialists discuss how to manage back pain during COVID-19. Please click on the 'play' video below.


Conveniently Located

Clinical Trials

  • INSYTE: Management of Parkinson’s Disease Psychosis in Actual Practice (The INSYTE Study)
    The INSYTE Study will examine the current disease progression of Parkinson’s disease Psychosis (PDP), the clinical, economic, and humanistic impact of anti-psychotic therapy in the management of the condition in real-world settings, and the burden of the condition on patients and their caregivers.
  • Protocol H8H-MC-LAIJ, Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
    The objective of this Phase 3 study is to evaluate the efficacy of lasmiditan 200 mg and 100 mg on migraine headache pain freedom compared to placebo.